|
|
The team at Health Discovery Corporation has identified and patent protected four new major discoveries.
|
|
1. A subset of genes that separates BPH from prostate cancer with a high degree of accuracy. This same set of genes also separates BPH from normal, indicating that BPH is a disease with molecular characteristics of its own.
2. An AIDS gene set that can separate AIDS brain cells from non-AIDS brain cells with a high degree of accuracy.
3. A subset of genes which indicate disease progression from less malignant to more malignant forms of prostate cancer. Such genes separate grade 4 prostate cancer, the most malignant form of prostate cancer, from less malignant grades of prostate cancer and normal tissues with a high degree of accuracy.
4. A set of leukemia genes that can separate ALL-T-cell leukemia from ALL-B-cell leukemia with a high degree of accuracy.
While we are extremely pleased with our accomplishments to date, we are even more excited about our future as we move into our commercialization and marketing phase of growth. Join us as we move towards becoming the worlds’ first fully integrated company dedicated to First-Phase Biomarker Discovery.
|
|
|
HDVY PATENTS AND PATENT APPLICATIONS
COLON CANCER
Application Ser. No.
10/033,570
Filed 1-11-2005
“Colon Cancer-Specific Markers”
PROSTATE CANCER
Application Ser. No.
10/627,626
Filed 11-12-2004
“Biomarkers for Screening, Predicting and Monitoring Prostate Cancer”
Application Ser. No.
10/651,340
Filed 2-9-2005
“Biomarkers for Screening, Predicting and Monitoring Prostate Cancer”
LEUKEMIA,
Application Ser. No.
60/161,806
Filed 10-27-1999
Application Ser. No.
60/675,760
HIV BRAIN INFECTION BIOMARKERS
Application 10/920,035
filed 8-17-2004
Application 10/920,058
filed 8-17-2004
Click here to view complete intellectual property portfolio.
|
|
